Bausch Health Companies
BHC
$0.05 (0.83%)
1D
1W
3M
1Y
5Y
ALL
Bausch Health Companies Inc. is a specialty pharmaceutical and medical device company. The Company develops, manufactures, and markets, primarily in the therapeutic areas of eye health, gastroenterology (GI), and dermatology, a range of branded, generic and branded generic pharmaceuticals, over the counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment and aesthetics devices) which are marketed directly or indirectly in approximately 100 countries. The Company operates through five segments: Bausch + Lomb, Salix, International, Solta Medical, and Diversified Products. The Bausch + Lomb segment consists of global sales of Bausch + Lomb Vision Care, Consumer, Surgical, and Ophthalmic Pharmaceuticals products. The Salix segment consists of sales in the United States of gastrointestinal (GI) products. The Solta Medical segment consists of global sales of Solta aesthetic medical devices.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Accesswire • 3 hours ago • BHC
Bausch Health Announces Health Canada Clearance of Solta Medical's Thermage(R) FLX SystemZacks Investment Research • 5 days ago • BHC
Will Bausch (BHC) Beat Estimates Again in Its Next Earnings Report?Zacks Investment Research • 6 days ago • BHC
Bausch Health (BHC) Reports Next Week: Wall Street Expects Earnings GrowthWSJ • 7 days ago • BHC
Bausch Health Learns Icahn Has 34% Economic Interest in SharesReuters • 7 days ago • BHC
Bausch Health says Carl Icahn has exposure to about 34% of company's sharesCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.